Obesity
Conditions
Interventions
Intervention details: Subjects were divided into two groups. Group 1 received no intervention, and in addition to nutritional guidance (once a month) and exercise guidance (once a month) as a regular
Sponsors
kansai medical university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria are eligible. 1) Patients who are 18 years of age or older at the time of obtaining consent 2) Outpatient/Inpatient, OutpatientO 3) Gender, Any 4) BMI is 27 kg/m2 or more 5) Complicated by hypertension or dyslipidemia 6) Those who are about to start drug treatment with semaglutide. 7) Those who meet the semaglutide package insert. Despite diet,exercise therapy, sufficient effects are not obtained and Have two or more obesity-related health disorders. 8) Patients who have received sufficient explanation and consent of their own free will to participate in this study with full understanding.
Exclusion criteria
Exclusion criteria: Patients who fall under any of the following will not be included in this study. 1) Patients with severe hepatic or renal dysfunction 2) Pregnant and lactating women 3) Patients with malignant tumor 4) Patients with severe heart failure/arrhythmia 5) Patients with secondary obesity due to endocrine (hormone) or other drugs, etc. 6) Patients with a history of hypersensitivity to semaglutide 7) Patients with diabetic ketoacidosis, diabetic coma or precoma, type 1 diabetes 8) Severe infections in patients with type 2 diabetes, conditions requiring emergency surgery, etc. 9) Other patients deemed unsuitable as research subjects by the research director
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight change rate from discontinuation of semaglutide to 24 weeks after discontinuation | — |
Countries
Japan
Contacts
Public ContactKAZUHISA TAKAHASHI
kansai medical university Department medicine II
Outcome results
None listed